Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Men with early hair loss may have higher risks of insulin resistance and metabolic issues.

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

New ultrasound criteria for diagnosing PCOS in North African patients were successfully established.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Combining stress management and Minoxidil helps treat stress-related hair loss and improve well-being.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Certain genetic variants may increase the risk of developing PCOS.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Constant light exposure during pregnancy changes newborn rabbits' skin, affecting hair follicles, skin thickness, and pigment cells.

Vitamin D is needed for metformin to lower prolactin effectively.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Growth hormone is important for regulating human hair growth.

Ashwagandha is safe and effective for reducing perimenopausal symptoms.

Hair follicle growth and fiber production in animals are influenced by chemical signals, proteins, pigmentation, genetics, and nutrients.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Severe menstrual issues in PCOS women signal higher risk for heart and metabolic problems.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.